Ankam, Inc.

Ankam, Inc. Annual Report Review: Navigating Growth and Risk

Ankam, Inc. is undergoing rapid transformation, and its latest SEC 10-K filing reveals a company aggressively pursuing growth amidst significant challenges. This summary provides retail investors with a clear, actionable overview of Ankam's performance, strategic direction, key opportunities, and critical risks.

1. Business Overview

Ankam, Inc. operates as a technology company, primarily developing and managing mobile applications. Its current portfolio features Expense Minder, an in-house app for personal and business expense management. It also includes MoneySaverApp, another expense management tool, which Ankam's subsidiary, Ankam LLC, acquired in late 2023. In January 2024, Ankam expanded its offerings by acquiring Apex Intelligence LLC, adding its Apex currency converter service.

Ankam's core business model relies on subscription-based services for its mobile applications. Beyond its app business, the company strategically expanded into the Asia-Pacific region, establishing Mei Sheng Corporation Limited in Hong Kong in late 2024. Mei Sheng is now actively developing a health products sales platform, signaling Ankam's broader strategic vision and diversification beyond traditional mobile apps.

2. Financial Performance

Ankam, Inc. achieved significant revenue growth but continues to struggle with profitability.

• Revenue Surge: Ankam reported $325,000 in revenue for the fiscal year ending November 30, 2025. This represents a remarkable 211% increase from $104,450 in the prior fiscal year (ending November 30, 2024). Its new subsidiary, Mei Sheng Corporation Limited, primarily drove this substantial growth through its expansion into the Asia-Pacific market.
• Profitability Concerns: Despite impressive revenue growth, Ankam posted a net loss of approximately $550,000 for FY2025, up from a $320,000 net loss in FY2024. Increased operating expenses from expansion and acquisitions outpaced revenue gains, preventing profitability. While a gross profit margin of approximately 65% suggests healthy service margins, high overheads negated these gains.
• Cash Flow Burn: Ankam reported negative operating cash flow of approximately $400,000 in FY2025, meaning it burned cash to fund operations and growth initiatives.

While revenue growth signals market traction, investors should note it has not yet translated into positive earnings or cash flow—critical for long-term sustainability.

3. Risk Factors

Investing in Ankam, Inc. carries significant risks that potential investors must carefully consider:

• Zero Market Value for Non-Affiliate Shares: This is a critical red flag. As of May 31, 2025, the reported $0 market value for shares held by "non-affiliates" (public shareholders not associated with company management) means no active public market exists for Ankam's stock. This makes shares extremely illiquid and difficult to sell, and prevents independent valuation of the company's equity. Ultimately, this makes the stock highly speculative and potentially worthless in the public market.
• Significant Funding Dependence & Going Concern Risk: With negative cash flow, limited cash reserves, and a cancelled convertible note, Ankam faces substantial challenges securing adequate funding to sustain operations and execute its growth strategy. The company may not continue as a "going concern" without significant additional capital.
• Lack of Detailed Risk Factors: As a "smaller reporting company," Ankam does not provide the same detailed risk disclosures as larger companies. This lack of transparency leaves investors with less official information about potential threats, increasing investment uncertainty.
• Intense Competition: The mobile app market, including expense management and currency conversion, is highly competitive and saturated with established players and new entrants. Ankam struggles with user acquisition, retention, and differentiation without substantial marketing and development resources.
• Operational Risks of Rapid Expansion & Diversification: Simultaneously integrating acquisitions (Apex), managing rapid international expansion (Mei Sheng), and developing new product lines (health platform) introduces complex operational risks. These include execution failures, cost overruns, and difficulties in market penetration.
• Regulatory & Geopolitical Risks in Asia: Expanding into the Asia-Pacific region exposes Ankam to diverse local regulations, evolving data privacy laws (e.g., health data regulations for Mei Sheng's platform), and potential geopolitical instability. These factors could impact business operations and profitability.
• Reliance on Key Personnel: Recent significant leadership changes mean the company's future heavily depends on the new management team's ability to execute its ambitious strategy and navigate financial challenges.
• Cybersecurity Risks: As a technology company handling financial and potentially health-related data, Ankam faces ongoing cybersecurity threats. Data breaches and system failures could result in financial losses, reputational damage, and regulatory penalties.

4. Management Discussion and Analysis (MD&A) Highlights

The past year has been transformative for Ankam, marked by significant strategic shifts, leadership changes, and evolving market and regulatory challenges.

• Strategic Shifts and Leadership: In August 2024, an investor group led by Wang Wen Lung acquired a controlling 77% stake in Ankam. Wang Wen Lung concurrently assumed the roles of President, CEO, Treasurer, and Director, signaling a complete overhaul of leadership and strategic direction. Three new directors joined the board in February 2026, further strengthening the new leadership. Their vision centers on accelerated growth, a strong geographic focus on the Asia-Pacific market, diversification into new sectors like health products, and leveraging strategic acquisitions to expand product offerings.
• Aggressive International Expansion: Ankam's establishment of Mei Sheng Corporation Limited in Hong Kong in late 2024 signals a strong push into the Asia-Pacific market. Mei Sheng not only expands the reach of existing services but also diversifies Ankam's portfolio with a new health products sales platform.
• Strategic Acquisition: Ankam acquired Apex Intelligence LLC in January 2024, adding a currency converter service and broadening its mobile app offerings. The company converted the $138,040 promissory note issued for this acquisition into common shares, reducing cash debt but increasing its share count.
• Funding Setback: Ankam faced a significant challenge with the cancellation of a $500,000 convertible note agreement in November 2024. This highlights potential difficulties in securing external financing and emphasizes the need for internal cash generation or alternative funding.
• Market Trends and Regulatory Environment: Ankam operates within dynamic market and regulatory landscapes. The mobile app market features intense competition, high user acquisition costs, and reliance on platform providers. Its fintech applications are subject to evolving data privacy regulations. International expansion into Asia-Pacific exposes Ankam to varying local business regulations, cultural nuances, and potential geopolitical risks. Developing a health products sales platform introduces new regulatory complexity, including rules for medical devices, pharmaceuticals, health data privacy, and consumer protection specific to health claims and product safety. Compliance will be crucial and potentially costly.

These developments indicate a company in rapid transition. New leadership aggressively pursues growth and diversification, particularly in international markets, while navigating complex operational and regulatory landscapes.

5. Financial Health

Ankam's financial health shows signs of strain, marked by limited liquidity and reliance on future financing.

• Limited Cash Position: As of November 30, 2025, Ankam held a cash balance of approximately $50,000. This low reserve, combined with negative operating cash flow, suggests tight liquidity.
• Working Capital Deficit: Ankam reported a working capital deficit of approximately $200,000, meaning its current liabilities exceed its current assets. This could challenge its ability to meet short-term obligations.
• Debt Management: Although Ankam converted the Apex acquisition's promissory note to equity, its overall financial health necessitates careful debt and capital management.
• No Dividends: Ankam paid no cash dividends in 2024 or 2025, typical for growth-focused companies reinvesting earnings.
• Funding Dependence: The cancelled $500,000 convertible note underscores Ankam's dependence on securing additional funding to support ambitious growth and cover ongoing operational losses.

6. Future Outlook

Ankam plans to continue developing its existing mobile applications, Expense Minder and MoneySaverApp. A key immediate focus is launching and scaling Mei Sheng's health products sales platform in the Asian market. The company also intends to increase advertising efforts as funds become available, aiming to grow its user base.

Securing the substantial capital required to fund ambitious growth, expansion, and ongoing operational losses remains a critical factor, especially after the $500,000 convertible note cancellation. Achieving profitability and positive cash flow is a key objective; management's execution of its strategy will be closely watched. Successful market penetration and user growth in both existing app markets and the new Asian health products platform are essential. New leadership focuses on managing operational complexities and achieving profitability amidst intense competition and financial constraints.

7. Competitive Position

Ankam operates in highly competitive segments of the mobile app market. In expense management, it competes with established players like Expensify, Mint, and various banking apps. Its Apex currency converter competes with numerous free and paid services.

Ankam's strategic differentiators include:

• Aggressive International Expansion: Focusing on the Asia-Pacific market through Mei Sheng, potentially targeting less saturated or underserved niches.
• Product Diversification: Moving into a health products sales platform through Mei Sheng represents significant diversification, aiming to tap new revenue streams and markets beyond its core app offerings.
• Agile Acquisition Strategy: The Apex acquisition demonstrates Ankam's potential to grow its portfolio through strategic purchases.

However, effective competition against larger, better-funded companies requires substantial investment in product development, marketing, and customer support—an area currently challenged by Ankam's financial position.

Conclusion: Ankam, Inc. is undergoing a significant strategic transformation under new leadership, marked by impressive revenue growth and ambitious international expansion into new product categories. However, this growth comes with substantial financial challenges: ongoing net losses, negative cash flow, and a critical lack of liquidity and market value for non-affiliate shareholders. Investors considering Ankam should carefully weigh the potential for future growth against the high risks associated with its financial health, funding dependence, and the extreme illiquidity of its stock.